CG Oncology, Inc. Common stockCGONNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-19.94
↑ 72% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthElevated
Average
-70.81
Historical baseline
PeriodValueYoY Change
2025-19.94+2.1%
2024-20.36+60.0%
2023-50.96+27.1%
2022-69.88+63.8%
2021-192.92-